IFP Advisors »

Outlook Therapeutics shares owned by IFP Advisors

Quarter-by-quarter ownership of Outlook Therapeutics (OTLK) shares owned by IFP Advisors from 13F filings

Historical chart of IFP Advisors investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by IFP Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by IFP Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $6 3 2.00

More positions owned by IFP Advisors

Apple cs (AAPL)
Nvidia Corporation cs (NVDA)
Vanguard Index Fds Growth Etf cs (VUG)
Spdr S&p 500 Etf Tr Tr cs (SPY)
Invesco Qqq Tr cs (QQQ)
Microsoft Corp cs (MSFT)
Ishares Tr S&p 500 Grwt Etf cs (IVW)
Spdr Series Trust Portfolio S&p500 cs (SPLG)
Ishares Gold Tr Ishares mc (IAU)
Amazon cs (AMZN)
Ishares Tr Core S&p500 Etf cs (IVV)
Ishares Tr S&p 100 Etf cs (OEF)
Wisdomtree Tr Us Qtly Div Grt mc (DGRW)
Spdr Index cs (SPDW)
Vanguard Index Fds S&p 500 Etf mc (VOO)

View all positions for IFP Advisors

Top funds holding Outlook Therapeutics

Vanguard Group
Schonfeld Strategic Advisors
Morgan Stanley
BlackRock
Geode Capital Management
Susquehanna International
Millennium Management
Commonwealth Equity Services
Simplex Trading
State Street Corporation
Scotia Capital
LVW Advisors
UBS Group
Citadel Advisors
Goldman Sachs Group

View all funds holding Outlook Therapeutics